Control of bone resorption by semaphorin 4D is dependent on ovarian function

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Dacquin, Romain ^a   Domenget, Chantal ^a   Kumanogoh, Atsushi ^b   Kikutani, Hitoshi ^b   Jurdic, Pierre ^a   Machuca Gayet, Irma ^a  

^a UNIVERSITÉ DE LYON   (France)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; GONADORELIN; SEMAPHORIN; CD100 ANTIGEN; LEUKOCYTE ANTIGEN;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE MARROW TRANSPLANTATION; BONE MASS; CELL ADHESION; CELL DAMAGE; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; FEMALE FERTILITY; GENE; GENE DELETION; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; OVARY FOLLICLE; OVARY FUNCTION; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEMAPHORIN 4D GENE; SEXUAL MATURITY; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; FEMALE; MALE; OVARIAN FUNCTION TEST; OVARY; PHYSIOLOGY; SEX DIFFERENCE;

MUS;

ANIMALS; ANTIGENS, CD; BONE RESORPTION; FEMALE; MALE; MICE; OSTEOCLASTS; OVARIAN FUNCTION TESTS; OVARY; SEMAPHORINS; SEX FACTORS;

EID: 80055047330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026627     Document Type: Article

References (35)

1. Nicks KM, Fowler TW, Gaddy D, (2010) Reproductive hormones and bone. Curr Osteoporos Rep 8: 60-67.
2. Seeman E, (2002) Pathogenesis of bone fragility in women and men. Lancet 359: 1841-1850.
3. Sutton AL, Zhang X, Dowd DR, Kharode YP, Komm BS, et al. (2008) Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice. Mol Endocrinol 22: 1370-1381.
4. Delorme G, Saltel F, Bonnelye E, Jurdic P, Machuca-Gayet I, (2005) Expression and function of semaphorin 7A in bone cells. Biol Cell 97: 589-597.
5. Koh JM, Oh B, Lee JY, Lee JK, Kimm K, et al. (2006) Association study of semaphorin 7a (sema7a) polymorphisms with bone mineral density and fracture risk in postmenopausal Korean women. J Hum Genet 51: 112-117.
6. Hwang JY, Lee JY, Park MH, Kim KS, Kim KK, et al. (2006) Association of PLXNA2 polymorphisms with vertebral fracture risk and bone mineral density in postmenopausal Korean population. Osteoporos Int 17: 1592-1601.
7. Takegahara N, Takamatsu H, Toyofuku T, Tsujimura T, Okuno T, et al. (2006) Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol 8: 615-622.
8. Kikutani H, Suzuki K, Kumanogoh A, (2007) Immune semaphorins: increasing members and their diverse roles. Adv Immunol 93: 121-143.
9. Zhu L, Bergmeier W, Wu J, Jiang H, Stalker TJ, et al. (2007) Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A 104: 1621-1626.
10. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, et al. (2005) Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105: 4321-4329.
11. Sierra JR, Corso S, Caione L, Cepero V, Conrotto P, et al. (2008) Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med 205: 1673-1685.
12. Giacobini P, Messina A, Morello F, Ferraris N, Corso S, et al. (2008) Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex. J Cell Biol 183: 555-566.
13. Oinuma I, Katoh H, Negishi M, (2004) Molecular dissection of the semaphorin 4D receptor plexin-B1-stimulated R-Ras GTPase-activating protein activity and neurite remodeling in hippocampal neurons. J Neurosci 24: 11473-11480.
14. Regev A, Goldman S, Shalev E, (2007) Semaphorin-4D (Sema-4D), the Plexin-B1 ligand, is involved in mouse ovary follicular development. Reprod Biol Endocrinol 5: 12.
15. Love CA, Harlos K, Mavaddat N, Davis SJ, Stuart DI, et al. (2003) The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nat Struct Biol 10: 843-848.
16. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, et al. (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105: 433-440.
17. Ross FP, Teitelbaum SL, (2005) alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 208: 88-105.
18. Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, et al. (2000) The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 13: 633-642.
19. Saltel F, Destaing O, Bard F, Eichert D, Jurdic P, (2004) Apatite-mediated actin dynamics in resorbing osteoclasts. Mol Biol Cell 15: 5231-5241.
20. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, et al. (2005) Vav3 regulates osteoclast function and bone mass. Nat Med 11: 284-290.
21. Wannemacher KM, Zhu L, Jiang H, Fong KP, Stalker TJ, et al. (2010) Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. Blood 116: 5707-5715.
22. Katsoff B, Check JH, (2008) Secondary amenorrhea with normal ovulatory cycles in a young virgin with normal follicle stimulating hormone levels-a case report. Clin Exp Obstet Gynecol 35: 147-148.
23. Touraine P, (2010) [Phenotype-genotype correlation in mutations of the gonadotrophin receptor gene in women]. Ann Endocrinol (Paris) 71: 203-205.
24. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, et al. (2006) FSH directly regulates bone mass. Cell 125: 247-260.
25. Li JY, Tawfeek H, Bedi B, Yang X, Adams J, et al. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci U S A 108: 768-773.
26. Allan CM, Wang Y, Jimenez M, Marshan B, Spaliviero J, et al. (2006) Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice. J Endocrinol 188: 549-557.
27. Allan CM, Kalak R, Dunstan CR, McTavish KJ, Zhou H, et al. Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci U S A 107: 22629-22634.
28. Gaddy D, (2008) Inhibin and the regulation of bone mass. Curr Osteoporos Rep 6: 51-56.
29. Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, et al. (2007) Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 148: 1654-1665.
30. Nicks KM, Fowler TW, Akel NS, Perrien DS, Suva LJ, et al. (2010) Bone turnover across the menopause transition: The role of gonadal inhibins. Ann N Y Acad Sci 1192: 153-160.
31. Anginot A, Dacquin R, Mazzorana M, Jurdic P, (2007) Lymphocytes and the Dap12 adaptor are key regulators of osteoclast activation associated with gonadal failure. PLoS ONE 2: e585.
32. Feng X, Novack DV, Faccio R, Ory DS, Aya K, et al. (2001) A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function. J Clin Invest 107: 1137-1144.
33. Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, et al. (2004) Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164: 509-514.
34. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
35. Myers M, Britt KL, Wreford NG, Ebling FJ, Kerr JB, (2004) Methods for quantifying follicular numbers within the mouse ovary. Reproduction 127: 569-580.